Cargando…
Calcineurin Inhibitors Synergize with Manogepix to Kill Diverse Human Fungal Pathogens
Invasive fungal infections have mortality rates of 30–90%, depending on patient co-morbidities and the causative pathogen. The frequent emergence of drug resistance reduces the efficacy of currently approved treatment options, highlighting an urgent need for antifungals with new modes of action. Add...
Autores principales: | Liston, Sean D., Whitesell, Luke, Kapoor, Mili, Shaw, Karen J., Cowen, Leah E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9605145/ https://www.ncbi.nlm.nih.gov/pubmed/36294667 http://dx.doi.org/10.3390/jof8101102 |
Ejemplares similares
-
Enhanced Efflux Pump Expression in Candida Mutants Results in Decreased Manogepix Susceptibility
por: Liston, Sean D., et al.
Publicado: (2020) -
Evaluation of Resistance Development to the Gwt1 Inhibitor Manogepix (APX001A) in Candida Species
por: Kapoor, Mili, et al.
Publicado: (2019) -
Multifactor transcriptional control of alternative oxidase induction integrates diverse environmental inputs to enable fungal virulence
por: Liu, Zhongle, et al.
Publicado: (2023) -
1275. Evaluation of in vitro activity of manogepix against multidrug-resistant and pan-resistant Candida auris from the New York Outbreak
por: Zhu, Yan Chun, et al.
Publicado: (2020) -
Calcineurin: The Achilles’ heel of fungal pathogens
por: Yadav, Vikas, et al.
Publicado: (2023)